NR 565 FINAL EXAM ADVANCED PHARMACOLOGY
(ACTUAL 2025/2026) EXAM 220 QUESTIONS WITH
VERIFIED ANSWERS GRADED A+ CHAMBERLAIN
MOA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors - <<
sitagliptin (Januvia) Saxagliptin(onglyza) Linagliptin (Tradjenta) Alogliptin(Nesina)
MOA Sulfonylureas - <<
Glyburide Glipizide Glimepiride
MOA Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors - <<
inhibiting SGLT-2 in the kidney tubules, decreasing glucose levels and inducing weight loss by caloric loss through the urine
canagliflozin (Invokana) dapagliflozin (Farxiga) empagliflozin (Jardiance)
Metoclopramide concerns - <<
Patient teaching for metronidazole - <<
Passive Immunity - <<
e.g. immunity is passed on from a mother to her infant or by artificial administration of antibody-containing formulations.
Active Immunity - <<
e.g. if a person who has never had hepatitis B contracts hepatitis B and recovers from it, that person becomes immune to hepatitis B because of the immune system's antibody response to the hepatitis B virus.
herd immunity - <<
e.g most of the people in the community are immune to an infectious disease, which means everyone does not need immunity to prevent the spread of the infection.
vaccine - <<
DTaP contraindications - <<
- / 3